来自瘤转录组学的监督治疗响应预测的机器学习框架:一项大规模的泛癌研究.
bioRxiv : the preprint server for biology
|December 31, 2025
概括
这项研究介绍了EXPRESSO,一种使用RNA数据预测癌症药物反应的机器学习模型. 它显示了个性化医疗的前景,优于现有方法,并突出了未来的研究方向.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 精确瘤学利用生物标志物进行量身定制的癌症治疗.
- 由于数据局限性和模型稀缺性,RNA转录组学在药物反应预测中未得到充分利用.
研究的目的:
- 开发一个强大的机器学习框架,用于预测患者对各种癌症治疗的反应,使用治疗前的转录基因数据.
- 创建用于药物反应预测的最大的转录组数据集.
主要方法:
- 在九种癌症类型和六种前线疗法中组建了一个大型数据集 (69个队列,3729名患者).
- 开发了EXPRESSO (EXpression-Profile-RESponSe-Optimizer),这是一个监督的机器学习模型,集成药物标和生物标志物.
- 评估了EXPRESSO的表现与20个已发表的转录密码签名相比.
主要成果:
- 在多种疗法中,EXPRESSO实现了显著的预测性能 (ROC-AUC 0.640.73,赔率比率2.44.6).
- 该模型的性能优于现有的20个转录基因签名.
- 稳定性分析表明一些疗法的性能高原,表明当前监督学习方法的潜在限制.
结论:
- 当用EXPRESSO等先进的机器学习分析转录数据时,可以有效地预测癌症治疗反应.
- 进一步的数据和机械建模可能会增强转录生物标志物的预测能力,用于个性化瘤学.
- 在利用RNA数据用于精确的癌症治疗选择方面,EXPRESSO代表了重大进步.
相关概念视频
Cancer Survival Analysis
626
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
626
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


